EMFAT
BHVN
Emerald Mutual Fund Advisers Trust’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-154,634
| Closed | -$22.5M | – | 232 |
|
|
2022
Q2 | $22.5M | Sell |
154,634
-108,256
| -41% | -$15.8M | 1.31% | 22 |
|
|
2022
Q1 | $31.2M | Buy |
262,890
+2,308
| +0.9% | +$274K | 1.38% | 19 |
|
|
2021
Q4 | $35.9M | Buy |
260,582
+35,181
| +16% | +$4.85M | 1.27% | 23 |
|
|
2021
Q3 | $31.3M | Buy |
+225,401
| New | +$31.3M | 1.08% | 33 |
|
|
2021
Q1 | – | Sell |
-76,124
| Closed | -$6.53M | – | 264 |
|
|
2020
Q4 | $6.53M | Sell |
76,124
-109,740
| -59% | -$9.41M | 0.23% | 118 |
|
|
2020
Q3 | $12.1M | Sell |
185,864
-253,284
| -58% | -$16.5M | 0.54% | 73 |
|
|
2020
Q2 | $32.1M | Sell |
439,148
-73,251
| -14% | -$5.36M | 1.52% | 10 |
|
|
2020
Q1 | $17.4M | Buy |
512,399
+53,790
| +12% | +$1.83M | 1.09% | 28 |
|
|
2019
Q4 | $25M | Buy |
458,609
+154,005
| +51% | +$8.38M | 1.02% | 26 |
|
|
2019
Q3 | $12.7M | Sell |
304,604
-1,438
| -0.5% | -$60K | 0.56% | 59 |
|
|
2019
Q2 | $13.4M | Sell |
306,042
-191,679
| -39% | -$8.39M | 0.53% | 71 |
|
|
2019
Q1 | $25.6M | Buy |
497,721
+17,403
| +4% | +$896K | 1.03% | 27 |
|
|
2018
Q4 | $17.8M | Buy |
480,318
+11,425
| +2% | +$422K | 0.83% | 40 |
|
|
2018
Q3 | $17.6M | Buy |
468,893
+123,103
| +36% | +$4.62M | 0.59% | 62 |
|
|
2018
Q2 | $13.7M | Buy |
345,790
+19,183
| +6% | +$758K | 0.5% | 84 |
|
|
2018
Q1 | $8.41M | Buy |
326,607
+43,109
| +15% | +$1.11M | 0.33% | 114 |
|
|
2017
Q4 | $7.65M | Buy |
283,498
+83,312
| +42% | +$2.25M | 0.3% | 116 |
|
|
2017
Q3 | $7.48M | Sell |
200,186
-152,374
| -43% | -$5.7M | 0.31% | 115 |
|
|
2017
Q2 | $8.81M | Buy |
+352,560
| New | +$8.81M | 0.38% | 96 |
|